13. Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details

Clinical trials : 3,340 /  Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238

  
2 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04798651
(ClinicalTrials.gov)		September 30, 202111/3/2021Pathogenicity of B and CD4 T Cell Subsets in Multiple SclerosisPathogenicity of B and CD4 T Cell Subsets in Multiple SclerosisMultiple Sclerosis;Clinically Isolated SyndromeBiological: blood sample;Biological: cerebro-spinal fluidUniversity Hospital, BordeauxUniversity of BordeauxRecruiting18 YearsN/AAll150N/AFrance
2NCT02142764
(ClinicalTrials.gov)		November 201415/5/2014Preliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis PatientsPreliminary Study for Selective Detection of the CD8+ Myelin Specific T Cell in the Blood of Multiple Sclerosis Patients (MS).Multiple SclerosisBiological: Blood samplesUniversity Hospital, BordeauxMerck Serono International SA;ADERACompleted18 YearsN/ABoth30N/AFrance